Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

DVAX Dynavax Technologies

Watchlist
11.825
+0.425+3.73%
Trading Session  02/02 12:41 ET
High
11.930
Open
11.530
Turnover
8.01M
Low
11.490
Pre Close
11.400
Volume
682.15K
Market Cap
1.51B
P/E(TTM)
5.19
52wk High
17.480
Shares
127.58M
P/E(Static)
20.75
52wk Low
7.260
Float Cap
1.50B
Bid/Ask %
-84.62%
Historical High
106.600
Shs Float
127.26M
Volume Ratio
0.91
Historical Low
1.500
Dividend TTM
--
Div Yield TTM
--
P/B
3.01
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.54%
Amplitude
3.86%
Avg Price
11.743
Lot Size
1
Float Cap
1.50B
Bid/Ask %
-84.62%
Historical High
106.600
Shs Float
127.26M
Volume Ratio
0.91
Historical Low
1.500
Dividend TTM
--
P/B
3.01
Dividend LFY
--
Turnover Ratio
0.54%
Amplitude
3.86%
Avg Price
11.743
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
CEO: Mr. Ryan Spencer
Market: NASDAQ
Listing Date: 02/19/2004
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist